长风药业股份有限公司（股票代码：02652）于2026年5月18日发布翌日披露报表，宣布当日通过香港联交所场内回购公司H股普通股1.80万股，约占该次回购前公司已发行股份0.006%。本次回购的每股价格介于20.48港元至20.76港元之间，合计支付金额约37.07万港元。
公告显示，截至2026年5月18日回购完成后，公司已发行股份数量为301,436,086股，库藏股数量增至787,500股，公司股份总数维持302,223,586股。本次股份回购将被列为库存股份。
公司已于2025年12月16日通过回购授权，允许回购股份总数最多为30,222,358股。公告同时披露，目前公司已依据该授权累计回购股份数目为787,500股，占授权通过当日公司已发行股份总数的约0.2606%。
长风药业在公告中确认，本次交易符合香港联交所证券上市规则及其他相关法律法规的要求。公告由执行董事及联席公司秘书朱玉玉签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.